Reviews

Role of Fcγ receptors in HER2-targeted breast cancer therapy
Antonino Musolino, William J Gradishar, Hope S Rugo, Jeffrey L Nordstrom, Edwin P Rock, Fernanda Arnaldez, Mark D Pegram

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003171; DOI: 10.1136/jitc-2021-003171
Immunogenic ferroptosis and where to find it?
Robin Demuynck, Iuliia Efimova, Faye Naessens, Dmitri V Krysko

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003430; DOI: 10.1136/jitc-2021-003430
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells
Yasmin Nouri, Robert Weinkove, Rachel Perret

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003065; DOI: 10.1136/jitc-2021-003065
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
Kirit Singh, Kelly M Hotchkiss, Aditya A Mohan, Jessica L Reedy, John H Sampson, Mustafa Khasraw

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003679; DOI: 10.1136/jitc-2021-003679
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
Maria Rain Jennings, David Munn, John Blazeck

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003013; DOI: 10.1136/jitc-2021-003013
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka Fucikova, An Coosemans, Sandra Orsulic, David Cibula, Ignace Vergote, Lorenzo Galluzzi, Radek Spisek

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002873; DOI: 10.1136/jitc-2021-002873
Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
Feiya Ma, Jensen Vayalil, Grace Lee, Yuqi Wang, Guangyong Peng

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003217; DOI: 10.1136/jitc-2021-003217
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
Alice Tzeng, Tony H Tzeng, Moshe C Ornstein

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003473; DOI: 10.1136/jitc-2021-003473
Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
James Harber, Tamihiro Kamata, Catrin Pritchard, Dean Fennell

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e003032; DOI: 10.1136/jitc-2021-003032
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, Lisa H Butterfield, Elizabeth M Jaffee, Christian A Koch, Bart O Roep, Arlene H Sharpe, William J Murphy, Alexandra-Chloé Villani, Theresa L Walunas

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002627; DOI: 10.1136/jitc-2021-002627

Main menu

Reviews

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Reviews

Pages